Companies Cryptocurrencies
Legend Biotech Corp
Legend Biotech Corp
Exchange: NasdaqGS
IPO Date: 04/06/2020
CEO: Dr. Yuan Xu Ph.D.
Biotechnology Healthcare 🔗
  • LEGN
  • 41.46
  • 6394292736
    market cap
  • 0.829998
If you bought

shares of Legend Biotech Corp (LEGN) on
You would have made
Old Price $12 Current Price $12

Legend Biotech Corp is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, LCAR-B38M/JNJ-4528, is an autologous CAR-T cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in a number of hematologic malignancies including multiple myeloma (MM). The Company have a portfolio of earlier-stage autologous product candidates targeting various cancers, including Non-Hodgkins Lymphoma (NHL), Acute Myeloid Leukemia (AML), and T cell Lymphoma (TCL). It is also developing an allogeneic CAR-T product candidate targeting CD20 for the treatment of NHL. The Company also has product candidates in early preclinical and clinical development for the treatment of solid tumors as well as infectious diseases.

Address: 2101 Cottontail Lane Somerset NEW JERSEY

Stay updated.